CNBC World

Pharma major Novartis falls nearly 10%, heading for worst day on record after three drug trial setbacks

Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.

This is a short WorldPing brief. The full report was published by CNBC World.

Read the full report at CNBC World

More coverage: all world news on WorldPing.

Related news